These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 16270757)

  • 21. Clinical overview of antihypertensive classes--clinically relevant differences: myths or facts? Based on a presentation by Alan H. Gradman, MD.
    Am J Manag Care; 2000 Mar; 6(4 Suppl):S197-210. PubMed ID: 10977460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How well have practices followed guidelines in prescribing antihypertensive drugs: the role of health insurance.
    Guo JD; Liu GG; Christensen DB; Fu AZ
    Value Health; 2003; 6(1):18-28. PubMed ID: 12535235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertension--new drug therapies. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure.
    Solomon J
    RN; 1994 Jan; 57(1):26-32; quiz 33. PubMed ID: 7905659
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence-based treatment of hypertension. JNC 7 Guidelines provide an updated framework.
    Lookinland S; Beckstrand RL
    Adv Nurse Pract; 2003 Sep; 11(9):32-9; quiz 39-40. PubMed ID: 14521107
    [No Abstract]   [Full Text] [Related]  

  • 25. Combination antihypertensive drugs: recommendations for use.
    Skolnik NS; Beck JD; Clark M
    Am Fam Physician; 2000 May; 61(10):3049-56. PubMed ID: 10839554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current status of antihypertensive prescription and associated blood pressure control in Japan.
    Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
    Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacoepidemiology of antihypertensive drugs in primary care setting of Bahrain between 1998 and 2000.
    Al Khaja KA; Sequeira RP
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):741-8. PubMed ID: 16342299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of systolic hypertension in the elderly.
    Hall WD
    Semin Nephrol; 1996 Jul; 16(4):299-308. PubMed ID: 8829268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [[Hypertension treatment of elderly men in Iceland].
    Sigurthardóttir V; Einarsson B; Sigfússon N; Hartharson T
    Nord Med; 1995; 110(4):119-22. PubMed ID: 7724355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study on intervention in arterial hypertension. Recommendations by experts and practical antihypertensive therapy. German Hypertension League].
    Trenkwalder P
    Fortschr Med; 1999 Feb; 117(6):24, 25-8, 30 passim. PubMed ID: 10095298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antihypertensive therapy in 357 inpatients of elderly isolated systolic hypertension].
    Zhai LH; Yang CY; Jiang KW; Xu XY; Lu HZ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):719-22, 725. PubMed ID: 16708819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac contractility and conduction: a comparison of antihypertensives.
    Greenberg B
    Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):30-4. PubMed ID: 1977305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug therapy for hypertension in hemodialysis patients.
    Hörl MP; Tepel M
    Minerva Med; 2005 Aug; 96(4):277-85. PubMed ID: 16179894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure.
    Schelleman H; Klungel OH; Witteman JC; Hofman A; van Duijn CM; de Boer A; Stricker BH
    Eur J Hum Genet; 2006 Jul; 14(7):860-6. PubMed ID: 16724011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antihypertensive treatment in diabetics].
    Katayama S
    Nihon Rinsho; 2001 May; 59(5):961-5. PubMed ID: 11391999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The outcome of STOP-Hypertension-2 in relation to the 1999 WHO/ISH hypertension guidelines.
    Lindholm LH
    Blood Press Suppl; 2000; 2():21-4. PubMed ID: 11055468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of calcium channel blockers for hypertension--a survey of a Cochrane review].
    Lederballe O; Ibsen H
    Ugeskr Laeger; 2011 Jun; 173(23):1647-50. PubMed ID: 21645484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of diabetic nephropathy].
    Barna I
    Orv Hetil; 2003 Jan; 144(4):165-72. PubMed ID: 12621814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.